CardioVascular BioTherapeutics, Inc. Uncategorized Contracts & Agreements
19 Contracts & Agreements
- AMENDMENT II to FIRMINVEST AG COMMITMENT LETTER (Filed With SEC on November 16, 2007)
- AMENDMENT to FIRMINVEST AG COMMITMENT LETTER (Filed With SEC on August 17, 2007)
- Postfach 1718 Stockerstrasse 48 8027 Zürich Telefon +41 44 288 36 36 Fax +41 44 288 36 11 (Filed With SEC on May 25, 2007)
- JOINT PATENT AGREEMENT February 28, 2007 (Filed With SEC on March 29, 2007)
- FIRST AMENDMENT (Filed With SEC on September 6, 2006)
- SECOND AMENDMENT (Filed With SEC on September 6, 2006)
- INDEMNITY AND REIMBURSEMENT AGREEMENT (Filed With SEC on March 21, 2006)
- CARDIOVASCULAR BIOTHERAPEUTICS, INC. 1,500,000 Shares (Filed With SEC on February 4, 2005)
- CARDIOVASCULAR BIOTHERAPEUTICS, INC. 2,000,000 Shares (Filed With SEC on January 31, 2005)
- MASTER AGREEMENT by and between MPI RESEARCH, INC. (hereinafter referred to as MPI) Mattawan, Michigan (Filed With SEC on November 26, 2004)
- DaVinci Biomedical research Prod. PROTOCOL TheEffect of Acidic Fibroblast Growth Factor on the Outcome of Hindlimb Ischemia in the Rat (Filed With SEC on November 26, 2004)
- DaVinci Biomedical research Prod. PROTOCOL Theeffect of Acidic Fibroblast Growth Factor on the outcome of Cerebral Ischemia in the Rat (Filed With SEC on November 26, 2004)
- DaVinci Biomedical research Prod. PROTOCOL ACTIVITY INVOLVING VERTEBRATE ANIMAL MODELS Cardiotoxicity Study of Fibroblast Growth Factor (FGF-1) in Dogs DaVinci Study Number: DB-19 (Filed With SEC on November 26, 2004)
- AGREEMENT on TECHNOLOGY & BUSINESS RIGHT TRANSFER between Cardio Vascular Genetic Engineering Inc. (a Delaware Corporation) (Filed With SEC on November 26, 2004)
- Exhibit 10.11 Catheter and Disposables Technology Inc., A division of CardioTech International 13845 Industrial Park Blvd., Plymouth, MN 55441 Phone: 763 ###-###-#### Fax: 763... (Filed With SEC on September 23, 2004)
- Exhibit 10.10 (Filed With SEC on September 23, 2004)
- DISTRIBUTORSHIP AGREEMENT (Filed With SEC on September 23, 2004)
- EXHIBIT 10.5 (Filed With SEC on September 23, 2004)
- EXHIBIT 10.3 (Filed With SEC on September 23, 2004)
